User profiles for "author:Emma Wall"

Emma Wall

Francis Crick Institute; University College London
Verified email at crick.ac.uk
Cited by 2489

Community-acquired bacterial meningitis

D van de Beek, MC Brouwer, U Koedel, EC Wall - The Lancet, 2021 - thelancet.com
Progress has been made in the prevention and treatment of community-acquired bacterial
meningitis during the past three decades but the burden of the disease remains high …

Neutralising antibody activity against SARS-CoV-2 VOCs B. 1.617. 2 and B. 1.351 by BNT162b2 vaccination

EC Wall, M Wu, R Harvey, G Kelly, S Warchal… - The Lancet, 2021 - thelancet.com
that emerged in the UK with the second COVID-19 wave in late 2020. The efficacy of
currently licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses …

[HTML][HTML] Acute bacterial meningitis

EC Wall, JM Chan, E Gil… - Current Opinion in …, 2021 - journals.lww.com
Acute bacterial meningitis : Current Opinion in Neurology Acute bacterial meningitis :
Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new …

[HTML][HTML] Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu… - Nature cancer, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune
monitoring (CAPTURE)(NCT03226886) is a prospective cohort study of COVID-19 immunity …

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC

EC Wall, M Wu, R Harvey, G Kelly, S Warchal… - The Lancet, 2021 - thelancet.com
The SARS-CoV-2 B. 1.617. 2 Delta variant of concern (VOC) continues to drive a sharp
increase in COVID-19 cases in the UK, with a current doubling time of 3· 5–16 days, 1 …

Osmotic therapies added to antibiotics for acute bacterial meningitis

ECB Wall, KMB Ajdukiewicz… - Cochrane Database …, 2018 - cochranelibrary.com
Background Every day children and adults die from acute community‐acquired bacterial
meningitis, particularly in low‐income countries, and survivors risk deafness, epilepsy and …

Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda

N Longley, C Muzoora, K Taseera… - Clinical infectious …, 2008 - academic.oup.com
Background. Therapy for human immunodeficiency virus (HIV)–associated cryptococcal
meningitis in many centers in Africa is fluconazole administered at a dosage of 400–800 mg …

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

EJ Carr, M Wu, R Harvey, EC Wall, G Kelly, S Hussain… - The Lancet, 2021 - thelancet.com
We sought to compare neutralising antibody responses between seronaive haemodialysis
patients and the healthy individuals we have already reported on as part of the Legacy …

[HTML][HTML] Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

A Fendler, STC Shepherd, L Au, M Wu, R Harvey… - The Lancet, 2022 - thelancet.com
Patients with cancer are at greater risk of severe COVID-19 and have been prioritised for
COVID-19 vaccination globally. We previously showed that following two doses of COVID …

[PDF][PDF] Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu… - Cancer Cell, 2022 - cell.com
Patients with cancer are at higher risk of severe COVID-19 (Grivas et al., 2021; Kuderer et
al., 2020), and they are currently prioritized globally for a third COVID-19 vaccine dose …